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ASSESSMENT OF PERIPHERAL ARTERIAL DISEASE IN DIABETIC 
FOOT ULCER IN SOUTH INDIAN POPULATION: A PROSPECTIVE 
STUDY 
 
INTRODUCTION 
Peripheral arterial disease (PAD) is manifested by chronic limb ischemia 
commonly due to atherosclerosis of the peripheral arteries. Diabetes mellitus is 
an independent risk factor for this disease. Thus, a diabetic patient with PAD is 
at increased risk to develop an ischemic ulcer or gangrene than a non-diabetic 
patient.  
Diabetic foot ulcer(DFU) is very common yet challenging complication of 
diabetes worldwide. The International Working Group on the Diabetic Foot 
defines  DFU as a full-thickness wound penetrating the dermis located below 
ankle in a diabetic patient. 
These ulcers are biologically compromised majorly by ischemia and 
neuropathy. Ischemia is gaining recognition as a significant cause of DFU.  
Significant differences exist in clinical characteristics, pathophysiology and 
treatment of ulcers associated with peripheral arterial disease(PAD) and non-
PAD ulcers. This has led to two different disease states namely DFU with PAD 
and without PAD. 
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Ankle-brachial-pressure index (ABI) is an important tool used at bedside to 
provide a measure of perfusion to the ankle, although not reliable in presence 
of calcified vessels. When combined with Doppler study,  this could facilitate 
early diagnosis and treatment reducing the potential risk of limb amputation. 
The indications for revascularization of an ischemic limb are incapacitating 
claudication and critical limb ischemia(CLI). Disabling claudication is a 
relative indication and one has to weigh the existing quality of life against the 
risk of procedure during selection of suitable patient  and it requires significant 
patient counseling. Revascularization in some ischemic limbs may be deferred 
if no target vessel present or unavailability of an autogenous vein. Even 
irreversible gangrene progressing beyond midfoot may preclude 
revascularization. In such patients a choice must be made between prolonged 
medical management and primary amputation. 
Major amputation in an ischemic foot is indicated only when there is life 
threatening sepsis or when arterial occlusion causing extensive necrosis has 
destroyed the foot.  
Most amputations can be prevented and limbs salvaged through a multimodal 
treatment of infection control, wound  debridement and revascularization 
procedures. However amputation may warrant a good quality of life, if a 
prolonged treatment course is anticipated with minimal likelihood of healing. 
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All diabetic patients should be offered full and active rehabilitation following 
limb amputation. 
Thus the association of PAD largely impacts the treatment outcomes in terms 
of ulcer healing, lower limb amputations and mortality. The burden of PAD in 
DFU in South Indian population has not been assessed adequately in the recent 
years. A prompt diagnosis of ischemia and multidisciplinary approach to DFU 
will decrease the loss of limb and life. This study aims to throw light on the 
same. 
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Effect of Peripheral Arterial Disease in Diabetic population 
PAD is characterized by atherosclerosis of lower extremity arteries causing 
occlusive disease. It is a strong predictive factor for atherothrombotic disease 
in other vascular beds. 
  
PAD  involvement is mostly diffuse and particularly is more severe in tibial 
vessels. It usually involves long segment occlusions. In a non-diabetic 
individual, collateral vessels develop in response to occlusion of a major artery. 
This collateral formation is impaired in diabetes rendering the distal tissue 
more prone to severe ischemia. 
 
Patient with PAD most commonly presents with a cramping pain in the calves, 
thighs or buttocks known as intermittent claudication. This pain relieved by 
rest and reappears with walking and exercise. Some patients present with 
extreme symptoms like rest pain, infected ulcer and gangrene. These limb-
threatening symptoms are collectively termed as critical limb ischemia (CLI). 
The strong risk factors for PAD are diabetes and smoking. The duration of 
diabetes, hypertension, hyperlipidemia and advanced age are the other 
established risk factors. 
In diabetic patients, occurrence of PAD increases with diabetic duration, 
advancing age and peripheral neuropathy. 
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 Most patients are asymptomatic or do not report symptoms due to ignorance. 
For some, pain is blunted by presence of neuropathy. Moreover there is no 
uniformly agreed consensus on screening modalities. For these reasons, the 
assessment of true prevalence of  PAD in diabetic patients becomes difficult. 
Hence in presence of diabetes, PAD is more likely to present at an advanced 
stage. 
 Two common assessment tools are presence of intermittent claudication and 
absence of distal foot pulses, both involving an element of insensitivity. For 
more accurate estimation of prevalence, the assessment should be based on 
reproducible and validated test like ankle-brachial index (ABI). 
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Evaluation of PAD in DFU 
Clinical evaluation 
The clinical evaluation should start with a detailed medical history enquiring 
about the onset and progression of disease. Risk factors should be enquired 
about and focus should be on identifying symptoms like claudication, rest pain 
and functional impairment. PAD patient may present in a diverse form from no 
symptoms to infected chronic ulcer and gangrene. Associated symptoms 
arising from atherothrombosis in other vascular beds like angina, stroke and 
abdominal ischemia should be noted. Alternative causes of claudication like 
spinal canal stenosis should be ruled out. 
Physical examination should start with attitude  of limb and presence of 
deformity. Detailed inspection of the affected limb involves looking for the 
signs of vascular insufficiency. These include muscle wasting and  loss of 
subcutaneous fat characterized by thinning of limbs with bony prominence. 
The skin becomes dry and fissured with reduced temperature. Nails are 
dystrophic, lusterless, brittle and contain transverse ridges. There is loss of  
skin hair make the skin appear shiny. The interdigital spaces should be 
inspected for ulcers and fissures.  
This should be followed by assessment of circulatory insufficiency like 
capillary refilling time, venous filling time(Harvey's sign) and Buerger's test. 
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Buerger's test involves assessing the leg elevation angle at which vascular 
compromise is obvious. Assessment of peripheral pulses  is most important 
which involves charting of lower and upper limb pulses. One has to auscultate 
these arteries and look for bruit. This has to be followed by assessment of 
neighboring joints for movements and deformity. Thorough assessment of 
motor system, sensory system of nerves and reflexes should be done. Finally 
draining lymph nodes should be examined. 
Non invasive test: ABI 
ABI provides an easy, reasonably accurate and non invasive assessment of 
occurrence of PAD. It also helps assessing the severity of the disease. It is a 
ratio in which the numerator is the highest of the three ankle systolic blood 
pressures in dorsalis pedis, anterior and posterior tibial arteries in the affected 
lower limb. The denominator is the highest of brachial systolic pressures 
measured in both the upper limbs. The pressures are measured by using hand 
held Doppler making it a very simple and quantitative tool to assess the 
patency of lower limb arteries 
However, in elderly, diabetic patients and in chronic kidney disease, the 
peripheral arteries are calcified and are poorly compressible and hence may 
artificially elevate the values. This complicate the evaluation of PAD. 
19 
 
The tools required to calculate ABI include a hand-held Doppler probe of 
frequency 5–10 MHz and a sphygmomanometer with blood pressure cuff. 
The ABI is measured by putting patient in supine position for 5 min. Systolic 
blood pressure in ankle is measured in posterior tibial artery and dorsalis pedis 
and by placing the cuff just above the ankle. Systolic blood pressure in arm  is 
measured in brachial artery by placing the cuff just above the elbow. 
ABI>1.3 indicates presence of  poorly compressible arteries at the ankle level 
due to medial arterial calcification which occurs commonly in diabetes. This 
renders diagnosis of PAD by ABI alone less reliable. 
Since the digital arteries are less commonly affected by calcification, toe 
pressure measurements involving digital arteries are more reliable in 
assessment of forefoot circulation in patients with diabetes.  A toe-brachial 
index of <0.7 or toe pressure of <55 mmHg strongly indicates PAD. 
Evaluation of the flow signals from arteries in foot using hand held Doppler 
revealing a monophasic or absent signal indicated sever ischemia. 
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Imaging modalities for PAD in diabetes 
Doppler ultrasound: 
Doppler ultrasound involves combining B-mode ultrasound  and pulsed 
Doppler flow to assess anatomy and physiology of blood flow in specific 
arterial segments. The entire lower extremity arterial circulation is evaluated by 
sequential scanning of  the abdominal aorta, iliac, femoral, popliteal and tibial 
arteries,.  
 
CT angiography: 
It is a minimally invasive modality to diagnose PAD. It involves use of 
iodinated contrast which is injected intravenously. For lower extremity, 
scanning is done from renal arteries to the distal foot . This is followed by 3D 
reconstruction of data. The advantage is that it provides high resolution images 
of small vessels in the calf. The disadvantage being use of radiation and 
potentially nephrotoxic contrast.   
 
Contrast-enhanced MR angiography: 
This is also a low invasive imaging technique for detecting PAD. Gadolinium 
is used as contrast.  
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Digital subtraction angiography 
Intra-arterial DSA is considered as the gold standard for imaging due to high 
spatial resolution of arteries. Endovascular revascularization can be performed 
in the same sitting. The risks involved are arterial puncture, hematoma, 
extravasation and contrast allergy. Preferably DSA should be performed only 
when revascularization is planned.  
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Medical management for PAD in DFU 
Asymptomatic PAD 
Life style modification 
This involves modification of daily activities and dietary pattern. 
Tobacco Smoking 
Counseling of patients to abstain from all tobacco products is the first and most 
essential step. In PAD, tobacco is believed to increase progression of the 
atherosclerotic disease and hence increases amputation risk. 
Blood sugar control 
Adequate  glycemic control to a tune of HbA1c < 7% is needed to prevent 
microvascular complications. 
Hyperlipidemia 
Many studies conclude that lipid lowering agents slow the disease progression 
and bring down deaths due to cardiovascular events.  
Antiplatelets 
Aspirin low dose exhibits antithrombotic effects and also slows down the clot 
propagation and reduce the cardiovascular complication. Those allergic to 
aspirin are put on clopidogrel.  
24 
 
Management of symptomatic PAD 
Exercise  
Moderate exercise within the limits of claudication distance is advised to 
improve the collateral blood supply and cardiovascular risk factor profile.  
Drug therapies 
Heparin is used to interfere with clotting mechanism and prevent further clot 
formation. However it does not act on existing clot. 
Pentoxifylline is a  hemorheologic modifier which is said to improve 
microcirculation by decreasing the  blood viscosity. 
Cilostazol is a phosphodiesterase III inhibitor acting as a vasodilator. It is 
contraindicated in heart failure. 
  
Foot care 
Patients should be counseling on foot care involving hygiene and specialized 
foot wear. Regular supervision reduces the risk of foot complications. 
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Treatment of ischemic foot 
 
Critical limb ischemia characterized by rest pain, tissue loss or gangrene is a 
limb-threatening condition which warrants emergent treatment. Peripheral 
neuropathy blunts the pain perception causing PAD to manifest late in a 
diabetic patient. Contrarily PAD accelerated nerve ischemia and worsened 
neuropathy.  
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In contrast to involvement of plantar aspect in neuropathic ulcers, ischemic 
ulcers commonly involve dorsum , edges of foot and toes. Conservative 
management includes wound debridement, ulcer offloading, appropriate 
dressing, and adjuvant wound healing methods. 
Wound Debridement 
Wound debridement should aim to remove all necrotic debris and slough to 
reduce infection. It should be done when there is presence of localized 
fluctuation, undermining of ulcer with slough, crepitus with gas in X-ray and 
need for drainage of pus. 
Appropriate footwear 
It is most important in case of a neuroischemic foot wear the aim is protection 
of foot from shear and pressure. Patients should be advised not to wear tight 
shoes. This would hinder ulcer healing. Ideal footwear should be long, deep 
and broad, designed to protect arch of foot and offload the pressure. This 
would automatically facilitate the ulcer healing.  
Dressings 
Dressing is applied to prevent tissue desiccation, absorb discharge, prevent 
external contamination. Occlusive dressing lowers risk of infection. Non 
adhesive dressings should cover foot ulcers at all times. Some properties like 
easy removability, accommodating foot pressures while walking and is 
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desirable. Various available dressings include foams, hydrogels, absorbent 
polymers, alginates, growth factor and skin replacement agents.  
 
Treatment of infection 
In a diabetic foot, the signs and symptoms of foot infection are often 
diminished due to impaired neuroinflammatory response.  
 
The isolates in diabetic foot sepsis are usually polymicrobial. Commonly 
streptococci, methicillin resistant staphylococcus(MRSA), enterobacteriaceae 
and pseudomonas are encountered. Often it is mixed infection with anaerobes.  
 
Appropriate empirical antibiotics should act against both gram positive and 
gram negative organisms and provide both aerobic and anaerobic coverage. 
Such wounds require intravenous antibiotics and these patients should be 
hospitalized. 
 
 Patients with mild to moderate infection, superficial ulcers without sepsis, 
localized cellulitis can be treated with oral antibiotics on an outpatient basis. 
The empirical antibiotics should be started after  initial cultures are taken and 
changed as needed. 
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Incision and drainage is the core of treatment for almost all diabetic foot 
infections. It may be supplemented with toe or ray amputation for facilitating 
drainage. Aggressive wound debridement and revascularization procedure 
usually make limb salvage possible.  
Neuroischemic foot may complicate into dry and wet gangrene. Septic arteritis 
following soft tissue infection and ulceration leads to wet gangrene. If gas in 
soft tissue is noted, immediate open drainage of all potentially infected spaces 
is necessary along with broad spectrum I.V. antibiotics.   
In acute on chronic limb ischemia, there is severe reduction in arterial 
perfusion leading to dry gangrene. Surgical wound debridement should be done 
only after revascularization if applicable. Only then the debrided foot will be 
perfused adequately to heal.  
 
 
Revascularization 
Revascularization can be carried out by open surgical technique or 
endovascular procedures. These two types of procedures are not mutually 
exclusive. They are combined in most of the cases like iliac angioplasty with 
bypass grafting with saphenous vein. 
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Endovascular procedures are preferred in focal segmental disease.  
Aortoiliac disease usually managed effectively with open aortofemoral 
prosthetic bypass but endovascular stenting is gaining significant recognition 
as an alternative. 
Superficial femoral artery stenosis can be treated by open femoropopliteal 
bypass. 
Bypass grafting with autogenous great saphenous vein is the common 
procedure for tibial disease. Nevertheless, endovascular procedures are 
increasingly becoming popular due to technical advances allowing aggressive 
use of tibial angioplasty. 
Major limb amputation is only indicated in case of life threatening sepsis in an 
ischemic foot. majority of limb amputations can be prevented by timely 
diagnosis and intervention by a combination of revascularization, wound 
debridement, infection control by antibiotics, and staged closure of wound.  
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WIFI-G Index 
The society of vascular surgeons formulated a new wound classification system 
WIFI based on wound, ischemia and foot infection. It is useful for risk 
stratification like other classification systems like Wagner, PEDIS, Texas. This 
study aims to incorporate this classification and test its correlation with PAD 
and limb amputation.  
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OBJECTIVES 
To know prevalence of  peripheral arterial disease in diabetic foot ulcer  
To assess the associated risk factors 
To test the correlation of WIFI-G score with severity of disease 
To assess the appropriateness of triple test and need for routine Doppler  in 
DFU to evaluate PAD 
To assess the limb salvage  
To compare the results with previous similar studies on DFU with PAD  
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MATERIALS AND METHODS 
PATIENT SELECTION:  
In-patients admitted with isolated diabetic foot ulcer were enrolled into the 
study. They were randomly selected from the surgical wards on every 7th day. 
A total of 100 patients were sampled.  
Study area: Department of General Surgery and Vascular Surgery,  
         Govt. Stanley Hospital 
INCLUSION CRITERIA: 
 Age group 35- 65yrs 
 Both sexes 
 In-patient 
 Known diabetic 
 Isolated foot ulcer 
 
EXCLUSION CRITERIA: 
Out patients  
Known case of peripheral vascular disease during admission 
Ulcer other than in foot 
Vasculitis 
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PERIOD OF STUDY: 9 months 
METHODOLOGY 
This is a prospective study which involved type 2 diabetic patients with 
isolated foot ulcer(DFU). Their history, clinical parameters and wound 
bacteriology were noted and documented. A total of 100 patients were 
evaluated in this study. The patients were subjected to detailed history by 
administering questionnaires to assess the diabetic foot ulcer and associated 
risk factors. A thorough clinical examination was carried out followed by 
specific examination which included distal pulse assessment, ankle-brachial 
index(ABI) and duplex scan to evaluate PAD. Portable hand held Doppler was 
used to measure ABI. 
The patients were followed up for a period of 3 months from definitive 
procedure to assess the ulcer healing and limb salvage. The data was subjected 
to statistical analysis to find out association between parameters of interest. 
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WIFI index is intended to be analogous to the TNM staging system for 
cancer  
A patient with diabetes, a shallow superficial foot ulcer, early cellulitis and an 
ABI of 0.43 with a TP of 25 mm Hg would be classified as follows:  
W1 I 2 FI 1 G 0 or WIFI-G 1210, with a Total Score of 4 (1+2+1=0)  
The highest possible score would be in a patient with severe ischemia (TP 15 
mm Hg), dorsal foot ulcer with penetration to bone, wet gangrene of 3 toes to 
G:- GANGRENE 
Grade  
 
Clinical Description  
0  None  
1  Ischemic rest pain- Pre-gangrenous 
skin changes 
Minor Gangrene - limited to mid-
distal digits. simple toe 
amputation(s) likely goal, up to a 
single ray amputation  
2  Moderate gangrene- > 2 toes, 
extending onto forefoot, likely to 
require TMA or more than single ray 
amputation  
3  Major gangrene- extensive gangrene 
> 10 cm2 or forefoot or midfoot, 
likely to require Chopart or Lisfranc 
amputation to achieve healing; full 
thickness heel gangrene > 5 cm2 
w/o calcaneal involvement  
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the bases and systemic sepsis: W3 I3 FI3 G3, WIFI-G 3333, generating a Total 
Score of 12  
It might be useful to analyze outcomes based on total as well as fractionated 
scores  
 
WOUND SWAB: 
2 swabs were taken, one from the edge of the spreading ulcer and another from 
the depth of the wound. Swabs taken before empirical antibiotic administration 
and wound debridement. 
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WORKUP PROTOCOL USED IN STUDY: 
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RESULTS 
The prevalence of PAD in DFU was found to be 36%(table 1, fig 1). It was 
more prevalent in males and in age>40 years and higher with increasing 
age(table 2). PAD was associated almost equally with plantar and dorsal ulcers, 
more often whole of foot was involved(p=0.008) (table 3, fig 2). There is 
significant association of PAD with high WIFI index(table 4,fig 3) and longer 
diabetic duration(p<0.0001) (table 7, fig 4) with mean disease duration of 10 
years.  
With only ABI as diagnostic criteria, occurrence of PAD was 28%, in another 
7% cases ABI could not assessed due to non-compressibility. Combining with 
Doppler study, occurrence was 36%.  
When >2 absent distal pulses by palpation alone was the criteria, occurrence of 
PAD was 24%. This could be due to  human error, presence of associated pedal 
edema and presence of collaterals. Biphasic flow in Doppler was associated 
with only 74% of PAD(table 12, fig 8). This could be attributed to human error 
or hypodynamic circulation in septic patients. 
Osteomyelitis is strongly associated with PAD(59%, p=0.003) (table 8, fig 5). 
PAD was associated with higher amputation rates(53.8%, p=0.003). Of minor 
lower limb amputations, only 47% were associated with PAD whereas of all 
major amputations, 87% were associated with PAD(p= 0.002) (table 14).  
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In a 3 month follow up, the ulcer healing was delayed in patients with 
PAD(~70 days) compared to non-PAD(~30 days). 
36 DFU patients diagnosed with PAD were referred for vascular surgery 
consultation, out of which 10 patients had severe ischemia were taken up for 
revascularization. After a 3 month follow up, complete ulcer healing without 
any amputation occurred in 3 patients , 2 patients had toe amputation with 
complete healing of wound, one patient had a subsequent BKA with complete 
healing of the stump and one patient subsequently expired after angioplasty 
due to MI. 2 patients were lost to follow up. Therefore 60% limb salvage was 
possible.  
Among the rest of 26 patients with PAD, 6 patients who were assessed to have 
adequate vascularity were put on best medical management and had complete 
ulcer healing.  
Out of the 20 patients with PAD, 6 underwent toe amputation, one patient 
underwent forefoot amputation with complete healing, 9 patients underwent 
BKA with complete healing of stump, 3 patients underwent AKA with 
complete healing, and one patient was lost to follow up. Since it is a tertiary 
setting, the referral was late and hence primary amputation was done as a life 
saving measure in these patients. 
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Major amputations were associated more with plantar foot ulcer(16%) whereas 
minor amputations were associated more with dorsal foot ulcer(33%) (table 
20). About 47% of ulcers involving whole of foot went in for major amputation 
while forefoot ulcers(33%) and midfoot ulcers(25%) commonly went in for 
minor amputations(p<0.0001) (table 21). 
Also higher amputation rates correlated with a high WIFI score(p<0.0001) 
(table 16, fig 11) and higher Fontaine grades(table 17, fig 12). Mean diabetic 
duration(9.8 yrs) (table 16) was found higher in those who underwent 
amputation(p=0.006).  
Wound culture  most commonly revealed a polymicrobial isolate(table 9, fig 6) 
followed by gram negative aerobes sensitive to Aminogycosides. Amikacin 
was sensitive to all the organisms in most of the cases(table 10, fig 7). 
Antibiotic resistance to Cefotaxime and Ceftriaxone was reported in few cases. 
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Table 1: Prevalence of PAD 
 Count Column N % 
PAD NO PAD 64 64.0% 
PAD 36 36.0% 
 
 
 
 
 
Fig 1: Prevalence of PAD 
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Table 2: Distribution of DFU 
 
PAD  
NO PAD PAD Total P 
Count Row % Count Row % Count Column N %  
age <40 4 80.0 1 20.0 5 5.0 0.2 
41-50 15 78.9 4 21.1 19 19.0 
51-60 30 63.8 17 36.2 47 47.0 
>61 15 51.7 14 48.3 29 29.0 
Sex Male 44 65.7 23 34.3 67 67.0 0.6 
Female 20 60.6 13 39.4 33 33.0 
Education 10th 10 76.9 3 23.1 13 13.0 0.4 
5th 1 100.0 0 .0 1 1.0 
nil 53 61.6 33 38.4 86 86.0 
Religion christian 2 33.3 4 66.7 6 6.0 0.06 
Hindu 59 68.6 27 31.4 86 86.0 
Muslim 3 37.5 5 62.5 8 8.0 
Socioeconomic status low 60 63.8 34 36.2 5 5.0 0.9 
middle 4 66.7 2 33.3 19 19.0 
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Table 3: Site of ulcer and PAD 
 
PAD  
NO PAD PAD Total  
Count Row N % Count Row N % Count columnN % P 
Side left 32 65.3 17 34.7 49 49.0 0.8 
right 32 62.7 19 37.3 51 51.0  
dorsum_plantar dorsum 53 65.4 28 34.6 81 81.0 0.5 
plantar 11 57.9 8 42.1 19 19.0  
Location of foot forefoot 55 72.4 21 27.6 76 76  
hindfoot 3 60.0 2 40.0 5 5  
midfoot 2 50.0 2 50.0 4 4  
whole foot 4 26.7 11 73.3 15 15 0.008 
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Fig 2: Site of ulcer and PAD 
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Fig 3:  Ulcer duration and WIFI-G score correlation with PAD
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Table 5:  Trauma, foot wear use and smoking in relation with PAD 
 
NO PAD PAD  
Count Row N % Count Row N % p 
Trauma no 55 64.0 31 36.0 0.9 
yes 9 64.3 5 35.7 
Footwear use no 2 40.0 3 60.0 0.2 
yes 62 65.3 33 34.7 
Smoking no 28 65.1 15 34.9 0.8 
yes 36 63.2 21 36.8 
 
 
 
 
 
 
 
Table 6: Co morbidities and PAD 
 
PAD  
NO PAD PAD  
Count Row N % Count Row N % P 
DM_Rx no 9 60.0 6 40.0 0.8 
yes 54 64.3 30 35.7  
Hypertension no 46 66.7 23 33.3 0.4 
yes 18 58.1 13 41.9  
CVA no 64 64.6 35 35.4 0.2 
yes 0 .0 1 100.0  
CAD no 60 64.5 33 35.5 0.7 
yes 4 57.1 3 42.9  
Nephropathy no 61 64.9 33 35.1 0.5 
yes 3 50.0 3 50.0  
Retinopathy no 64 64.0 36 36.0  
yes 0 .0 0 .0 NA 
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Fig 6: Diabetic duration  and PAD 
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Table 8: Osteomyelitis and PAD 
 
PAD 
NO PAD PAD 
Count Row N % Count Row N % 
Osteomyelitis no 53 72.6 20 27.4 
yes 11 40.7 16 59.3 
P=0.003 
 
 
 
 
 
Fig 5: Osteomyelitis and PAD 
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Table 12: Distal pulses, Doppler flow and Fontaine grading in PAD 
 
PAD  
NO PAD PAD  
Count Row N % Count Row N % p 
Absent distal pulses No 64 84.2 12 15.8  
Yes  0 .0 24 100.0 <0.0001 
Doppler flow Normal 55 100.0 0 .0  
No flow 0 .0 12 100.0  
Monophasic 0 .0 4 100.0 <0.0001 
Biphasic 7 25.9 20 74.1  
Fontaine grade .00 64 100.0 0 .0  
1.00 0 .0 7 100.0  
2.00 0 .0 10 100.0 <0.0001 
3.00 0 .0 8 100.0  
4.00 0 .0 11 100.0  
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Fig 8: Distal pulses, Doppler flow and Fontaine grading in PAD 
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Table 15: Lower limb amputation in PAD 
 
PAD 
NO PAD PAD 
Count Row N % Count Row N % 
amputation no 46 75.4 15 24.6 
yes 18 46.2 21 53.8 
 
P=0.003 
 
 
 
Fig 10: Lower limb amputation in PAD
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Fig 9: Lower limb amputation type and PAD 
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Table 13: Lower limb amputation level in PAD 
 
PAD 
NO PAD PAD 
Count Row N % Count Row N % 
Amputation 0  46 75.4 15 24.6 
Bka 1 16.7 5 83.3 
bka,aka 0 .0 1 100.0 
forefoot amputation 4 57.1 3 42.9 
toe amputation 13 52.0 12 48.0 
 
P=0.01 
 
 
 
 
 
Table 14: Lower limb amputation type and PAD 
 
PAD 
NO PAD PAD 
Count Row N % Count Row N % 
ampute No amputation 46 75.4 15 24.6 
Minor Amputation 17 53.1 15 46.9 
Major Amputation 1 14.3 6 85.7 
P=0.002 
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Table 11: Neuropathy and venous disease associated with DFU 
 
PAD  
NO PAD PAD  
Count Row N % Count Row N % p 
Neuropathy no 48 66.7 24 33.3 0.4 
yes 16 57.1 12 42.9  
venous disease no 61 63.5 35 36.5 0.7 
yes 3 75.0 1 25.0  
PulseU#L# no 0 .0 1 100.0  
yes 64 64.6 35 35.4 0.2 
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Table 16: Correlation of WIFI-G score and diabetic duration with lower limb amputation in 
DFU 
 
Amputation   
no yes  
Mean Median 
Standard 
Deviation Mean Median SD 
p 
WIFIG Score 2.98 2.00 1.27 7.15 7.00 2.11 <0.0001 
Diabetes_durationyears 7.6 5.0 5.9 9.8 8.0 6.5 0.06 
 
 
 
 
 
 
 
Fig 11: Correlation of WIFI-G score with lower limb amputation in DFU 
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Table 17: Association of risk factors with lower limb amputation in DFU 
 
Amputation   
No Yes  
n % n % P 
Age  <40 2 40.0 3 60.0 0.2 
41-50 11 57.9 8 42.1  
51-60 34 72.3 13 27.7  
>61 14 48.3 15 51.7  
Sex Male 43 64.2 24 35.8 0.6 
Female 18 54.5 15 45.5  
Fontaine grade .00 46 71.9 18 28.1  
1.00 5 71.4 2 28.6 0.02 
2.00 3 30.0 7 70.0  
3.00 3 37.5 5 62.5  
4.00 4 36.4 7 63.6  
CAD no 57 61.3 36 38.7 0.9 
yes 4 57.1 3 42.9  
prev_amput no 51 63.8 29 36.3  
yes 10 50.0 10 50.0 0.3 
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Fig 12: Association of Fontaine grade with lower limb amputation in DFU 
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Table 18: Distribution of Osteomyelitis, lower limb amputation and bacteriology in DFU 
 Count Column N % 
Osteomyelitis no 73 73.0% 
yes 27 27.0% 
amputat no 61 61.0% 
yes 39 39.0% 
organism Polymicrobial 45 45.5% 
Klebsiella 47 47.5% 
Proteus 36 36.4% 
Ecoli 12 12.1% 
Pseudomonas 8 8.1% 
Acinetobacter 1 1.0% 
sensitivity Cefotaxime 14 14.3% 
ceftriaxone 10 10.2% 
cefperazone 4 4.1% 
ceftazidime 2 2.0% 
amikacin 64 65.3% 
imipenem 5 5.1% 
piptaz 6 6.1% 
 
 
 
 
 
 
Table 20: Site of ulcer and amputation 
 
dorsum_plantar 
dorsum plantar 
Count Column N % Count Column N % 
ampute No amputation 50 61.7% 11 57.9% 
Minor Amputation 27 33.3% 5 26.3% 
Major Amputation 4 4.9% 3 15.8% 
 
P=0.2 
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Table 21: Site of ulcer and amputation type 
 
locationoffoot 
forefoot hindfoot midfoot whole foot 
Count 
Column N 
% Count 
Column N 
% Count 
Column N 
% Count 
Column N 
% 
ampute No amputation 48 63.2% 5 100.0% 3 75.0% 5 33.3% 
Minor 
Amputation 
28 36.8% 0 .0% 1 25.0% 3 20.0% 
Major 
Amputation 
0 .0% 0 .0% 0 .0% 7 46.7% 
P<0.0001 
 
 
 
 
 
 
Table 22: Revascularization and amputation 
 
Revascular 
No Yes 
Count Column N % Count Column N % 
ampute No amputation 53 58.9% 8 80.0% 
Minor Amputation 30 33.3% 2 20.0% 
Major Amputation 7 7.8% 0 .0% 
 
P=0.4 
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Table 9: Pus culture isolates in DFU 
Organism 
PAD  
NO PAD PAD  
Count 
Column Total N 
% Count 
Column Total N 
% 
P 
Polymicrobial 26 40.6 19 52.8 0.3 
Klebsiella 34 53.1 13 36.1 0.2 
Proteus 21 32.8 15 41.7 0.4 
Ecoli 7 10.9 5 13.9 0.8 
Pseudomonas 5 7.8 3 8.3 1 
Acinetobacter 0 .0 1 2.8 0.4 
 
 
 
 
 
 
Fig 6: Pus culture isolates in DFU 
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Table 19: Distribution of drug sensitivity in common culture isolates 
 
Sensitivity 
Cefotaxime ceftriaxone cefperazone ceftazidime Amikacin imipenem piptaz 
n % n % n % n % n % n % n % 
organism Polymicrobial 7 16.3 2 4.7 1 2.3 1 2.3 27 62.8 5 11.6 3 7.0 
Klebsiella 9 19.6 5 10.9 2 4.3 1 2.2 32 69.6 2 4.3 0 .0 
Proteus 5 14.3 3 8.6 1 2.9 0 .0 22 62.9 2 5.7 4 11.4 
Ecoli 0 .0 2 16.7 0 .0 0 .0 8 66.7 1 8.3 1 8.3 
Pseudomonas 0 .0 0 .0 3 37.5 1 12.5 2 25.0 1 12.5 2 25.0 
Acinetobacter 0 .0 0 .0 0 .0 0 .0 1 100.0 0 .0 0 .0 
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Table 10: Drug sensitivity and DFU 
Drug 
sensitivity 
PAD  
NO PAD PAD  
Count % Count  % p 
Cefotaxime 6 9.4 8 22.2 0.1 
ceftriaxone 8 12.5 2 5.6 0.3 
cefperazone 2 3.1 2 5.6 0.6 
ceftazidime 1 1.6 1 2.8 1 
amikacin 41 64.1 23 63.9 01 
imipenem 4 6.3 1 2.8 0.7 
piptaz 6 9.4 0 .0 0.09 
 
 
 
 
Fig 7: Drug sensitivity and DFU 
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DISCUSSION 
Previous studies aimed to study prevalence of PAD in diabetic population 
irrespective of foot ulcer. This study aimed to assess the burden of PAD in 
specific subset(DFU) of diabetic patients and the prevalence is 36%. A south 
Indian study(CUP) reported prevalence of  peripheral arterial disease as 11.8%.  
Mohan et al have reported on the prevalence of PAD in South Indian diabetics 
to be 3.9%. They compared their results with that of western studies, where the 
prevalence ranged between 22% and 45%.  
 Another study from South India reported  a lesser prevalence of PAD (13%) 
among Indians. 
A similar study from Greece reported prevalence of 42%.  
In a study based on a tertiary setting in Eastern India by Sahana et al, 141 
(34.4%) patients were diagnosed with PAD(ABI<0.9).  PAD occurred in 46% 
of subjects with foot ulcerations compared to 32.7% of subjects without foot 
ulceration.  
Mohan et al concluded that prevalence of PAD in diabetics increased with 
advancing age, with diabetic duration, from 15% at 10 years to 45% at 20 years 
from the diagnosis of diabetes. 
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In a study among Central Indian population by Pendsey et al, Diabetic 
duration<10 yrs had 30% associated PAD, whereas when duration was >10yrs, 
the association doubled to 60%. 
 
Study  Year  Occurrence  of PAD  
   
In diabetes  In diabetic foot 
ulcers  
Shojaie Fard et al.  2007   30%  
Probal K. Moulik et al  2003   41%  
Ikem R et al  2010   25.7%(>2 
absent distal 
pulses)  
55.4% (ABI 
with hand held 
Doppler)  
UKPDS  2008  
U.K.  
1.2%(at diagnosis)  
11%(after 6yrs)  
 
Mohan et al  1995  
South India  
3.9%   
  X    (10yrs)  
3X   (20yrs)  
 
Pendsey et al  1997  
Central India  
3.9%  
X     (10yrs)  
2X   (>10yrs)  
 
Sahana et al  Eastern India  34.4%  46%  
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In our study, PAD prevalence was 36% which was higher in comparison to 
most of the other studies. This could be attributed to many causes including 
large percentage of patients with foot complications attending  a tertiary care 
centre like our hospital, specific target population of DFU and triple 
assessment criteria.  
 
 absent distal 
pulses  
ABI  ABI + Duplex  
PAD  24%  28%  36%  
    
Non-
compressibility 
 7%   
 Edema, 
Collaterals, 
human error  
  
 
In a study by Jyothylekshmy et al, Culture report on foot ulcer patients 
revealed that Gram-positive Staphylococcus species (18.8%) and the Gram-
negative Pseudomonas species (18.2%) were the predominant organisms.  
Gram-positive aerobic bacteria was reported to be the commonest isolate in 
diabetic foot infections in many studies but recent investigations reported a 
predominance of Gram-negative aerobes. Fluoroquinolones were the most 
commonly used empirical antibiotics in this study as it has broad spectrum of 
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activity, relatively safe, and cost effective antibiotic compared to the other 
antibiotics.   
However in some studies, monomicrobial isolates were most common. This 
kind of discrepancy may be attributed to varying geography or infection 
severity in different hospitals included in the studies.  
 
 Jyothylekshmi 
et al  
Gadipalli  X  OUR STUDY  
Isolate  Gram positive  
aerobic 
Gram negative   
aerobic 
Monomicrobial  Polymicrobial  
Gram negative 
aerobic 
 
 
In this study,  Cephalosporins followed by flouroquinolones was the most 
prescribed empirical antibiotic . The most common culture isolates were 
polymicrobial consisting of gram negative aerobes.  
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Taylor et al reported that ischemic patients without revascularization had the 
worst outcomes. Chang TY et al in a study in Taiwan reported a limb salvage 
rate of 36% in revascularized patients. 
In a 3 month follow up in our study, the ulcer healing was delayed in patients 
with PAD compared to non-PAD. 60% limb salvage was possible with 
revascularization. The amputation rates were higher(65%) in the non-
revascularized group.  
Ulcer healing occurred in revascularized and non-revascularized group of 
patients and was quicker in the revascularized group(PAD). The mean hospital 
stay duration and drug expenditure was lower in the revascularized patients. 
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CONCLUSION 
The prevalence of PAD in DFU is high in South Indian. The present study 
analyzed occurrence of PAD and various factors coexisting with DFU and 
PAD.  
Increasing age and longer duration of diabetes are risk factors for  peripheral 
arterial disease. High prevalence puts DFU at a higher risk of amputation. 
 
The prevalence of PAD is found to be 36%.  Patients with  high risk factors 
associated with PAD like male, age>40 yrs, ulcer involving whole of foot, high 
WIFI-G score with diabetic duration> 10yrs, should be dealt with a strong 
suspicion of PADs 
Strong association with osteomyelitis, higher amputation rates and longer 
hospital stay warrants a screening for PAD in all DFU. 
WIFI-G scoring should be incorporated in the clinical assessment of wound 
due to its positive correlation with likelihood of amputation and PAD.  
The use of hand held Doppler will aid early diagnosis in a reliable and cost-
effective manner.  Moreover, a triple assessment criteria involving distal pulse 
charting, ABI and Doppler study should be followed to properly diagnose a 
PAD at the earliest. 
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Based on the bacteriological data acquired by doing hospital based study, 
institutional antibiotic protocol should be formed for empirical treatment of the 
diabetic foot to counter the antibiotic resistance. 
Once PAD diagnosed, patient should be counselled and categorized according 
to the appropriate management, and if found fit for revascularization should be 
done at the earliest onset to attain the benefit of limb salvage. 
The patients who underwent revascularization had lower rates of major 
amputation and limb loss. 
Nonetheless, in patients not fit for revascularization, the rates of major 
amputation were appreciable and ulcer healing was delayed. 
The results conclude that peripheral arterial disease is a potential risk factor for 
delayed wound healing and major limb amputations in DFU. 
Our data emphasizes the need for further dedicated research to identify and 
target this high risk population of DFU. 
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Strength and weakness of the study 
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                                                PROFORMA 
S. No.                      DOA                             Contact: 
Name                                  Age/Sex                         IP. No.                           
Occupation                                                                           
Education                           Religion                        Socioeconomic status    
Site of ulcer: 
Size of ulcer: 
Duration of ulcer: 
Wound depth              Ischemia                    Foot infection             Gangrene                 
WIFI-G score: 
Previous hospitalization: 
Trauma            Smoking             Hypertension             CAD             CVA 
Retinopathy           Nephropathy         DM x 
Footwear use 
X-ray foot: 
Wound culture: Organisms                                            
                           Antibiotic  
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Bone culture:  Organisms      
                        Antibiotic 
MRI Foot: 
Neuropathy: Vibration sense     2-point discrimination: 
Venous system: Superficial             
                           Deep 
 
Pulses:              Right    Bruit     Pressure                 Left      Bruit      Pressure 
U.L. 
STA 
CCA 
SCA 
AA 
BA 
RA 
UA 
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L.L. 
CFA 
PA 
PT 
AT 
DPA 
ABI 
 
Doppler/Duplex Scan: 
CT Angiogram: 
Limb ischemia/Fontaine: 
 
Medical management: Heparin(   )   Aspirin/Clopidogrel(   )   Acitrom(   )          
Antibiotics:      
Total duration: 
Angioplasty/Stenting: 
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Debridements:  
Amputation: 
Minor 
Major 
Duration of hospital stay: 
FOLLOW UP                Clinical  Ulcer       ABI       
Intervention 
1
st
  month 
 
2
nd
 month 
 
3
rd
 month 
Limb Salvage: 
Amputation free survival(3 months): 
MALE: 
MACE: 
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MASTER CHART 
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GOVT.STANLEY MEDICAL COLLEGE, CHENNAI- 600 001 
 
INFORMED CONSENT 
 
“Assessment of peripheral arterial disease in diabetic foot ulcer: A prospective study” 
 
PLACE OF STUDY: GOVT. STANLEY MEDICAL COLLEGE, CHENNAI 
 
NAME AND ADDRESS OF PATIENT: 
 
I, _____________________ have been informed about the details of the study in my own language. 
I have completely understood the details of the study. 
I am aware of the possible risks and benefits, while taking part in the study. 
I understand that I can withdraw from the study at any point of time and even then, I will continue to 
receive the medical treatment as usual. 
I understand that I will not get any payment for taking part in this study. 
I will not object if the results of this study are getting published in any medical journal, provided my 
personal identity is not revealed. 
I know what I am supposed to do by taking part in this study and I assure that I would extend my full 
co-operation for this study. 
 
Name and Address of the Volunteer:    Name and signature of investigator: 
 
 
Signature/Thumb impression of the Volunteer   Date: 
 
Date: 
 
 
Witnesses: 
(Signature, Name & Address) 
 
Date: 
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அரசு  ஸ்டான்லி  மருத்துவகல்லூாி,  சென்னை – 600001 
Assessment of peripheral arterial disease in diabetic foot ulcer: A prospective study 
நான் இந்த ஆராய்ச்ெியில்விவரங்கனை முற்றிலும் புாிந்து சகாண்டடன். 
ஆய்வில் பங்கு எடுத்துடபாது, ொத்தியமாை அபாயங்கள் மற்றும் பயன்கனை பற்றி நான் 
அறிந்துள்டைன். 
நான் எந்தசவாரு டவனையிலும் ஆய்வில் இருந்துதிரும்பமுடியும், அதன்பின்ைர், 
நான்வழக்கம்டபால் மருத்துவெிகிச்னெ சபற முடியும் என்று புாிந்து சகாள்கிடறன் 
நான் ஆய்வில் பங்கு எடுத்து பணம் எனதயும் சபறமுடியாது என்று அறிந்துள்டைன். இந்த 
ஆய்வின் முடிவுகள் எந்த சமடிக்கல் ஜர்ைலில் சவைியிடப்பட இருந்தால் நான் 
எதிர்க்கவில்னை, என் தைிப்பட்ட அனடயாைத்னத சவைிப்படுத்தப்பட்டு இருக்ககூடாது. 
நான் இந்த ஆய்வில் பங்சகடுப்பதன் மூைம் நான் என்ை செய்ய டபாகிடறன் என்று சதாியும் 
நான் இந்த ஆய்வில் என் முழு ஒத்துனழப்னபயும் சகாடுப்டபன் என்று உறுதியைிக்கிடறன். 
 
தன்ைார்வைர்      ொட்ெி  
 
சபயர் மற்றும் முகவாி     சபயர் மற்றும் முகவாி 
 
னகசயாப்பம் / விரல் டரனக    னகசயாப்பம் / விரல் டரனக: 
 
 
 
ஆராய்ச்ெியாைராக 
னகசயாப்பம் மற்றும் டததி 
